Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene as risk factors for Alzheimer's disease

被引:7
作者
Bratosiewicz-Wasik, Jolanta [1 ]
Liberski, Pawel P. [2 ]
Peplonska, Beata [3 ]
Styczynska, Maria [3 ]
Smolen-Dzirba, Joanna [4 ]
Cycon, Mariusz [4 ]
Wasik, Tomasz J. [4 ]
机构
[1] Med Univ Silesia, Sch Pharm, Dept Biopharm, Div Lab Med Sosnowiec, Katowice, Poland
[2] Med Univ Lodz, Dept Mol Pathol & Neuropathol, Lodz, Poland
[3] Polish Acad Sci, Mossakowski Med Res Ctr, Dept Neurodegenerat Disorders, Warsaw, Poland
[4] Med Univ Silesia, Sch Pharm, Dept Microbiol & Virol, Div Lab Med Sosnowiec, Katowice, Poland
关键词
Alzheimer's disease; Apolipoprotein E; APOE promoter; Single nucleotide polymorphism; APOE PROMOTER POLYMORPHISMS; INDEPENDENT RISK; LINKAGE DISEQUILIBRIUM; ASSOCIATION; POPULATION; -491A/T; ALLELE; DEMENTIA;
D O I
10.1016/j.neulet.2018.07.010
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by a complex aetiology. The epsilon 4 allel of the apolipoprotein E gene (APOE) is the only confirmed genetic risk factor for the development of AD. In addition, polymorphisms at the promoter region of the APOE gene are assumed to modulate the susceptibility to AD by their different affinity to the transcription factors thus affecting the expression of the gene. In the presented study, we investigated the association between - 491 Air (rs449647), - 427C/T, (rs769446) and -219 T/G (rs405509) single nucleotide polymorphisms (SNPs) of APOE gene and AD risk in the Polish population. We found that only the -491 T allele and -491 A/T genotype acted as protective factors against AD, whereas the -219 T/G heterozygosity increased risk for AD in APOE epsilon 4 carriers but not in APOE epsilon 4 non-carriers. What is more, haplotype frequency estimation showed significant positive for A-T-T-C-C and A-T-G-C-C haplotypes or negative for A-T-T-T-C and T-T-T-T-C haplotypes associations with AD. These results contribute to the evidence that APOE promoter polymorphisms modulate risk for AD.
引用
收藏
页码:86 / 90
页数:5
相关论文
共 27 条
  • [11] Apolipoprotein E and Apolipoprotein E Receptors: Normal Biology and Roles in Alzheimer Disease
    Holtzman, David M.
    Herz, Joachim
    Bu, Guojun
    [J]. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2012, 2 (03):
  • [12] Amyloid β40/42 clearance across the blood-brain barrier following intra-ventricular injections in wild-type, apoE knock-out and human apoE3 or E4 expressing transgenic mice
    Ji, Yong
    Permanne, Bruno
    Sigurdsson, Einar M.
    Holtzman, David M.
    Wisniewski, Thomas
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2001, 3 (01) : 23 - 30
  • [13] ApoE-491A/T promoter polymorphism is not an independent risk factor, but associated with the ε4 allele in Hungarian Alzheimer's dementia population
    Juhász, A
    Palotás, A
    Janka, Z
    Rimanóczy, A
    Palotás, M
    Bódi, N
    Boda, K
    Zana, M
    Vincze, G
    Kálmán, J
    [J]. NEUROCHEMICAL RESEARCH, 2005, 30 (05) : 591 - 596
  • [14] Apolipoprotein E in Synaptic Plasticity and Alzheimer's Disease: Potential Cellular and Molecular Mechanisms
    Kim, Jaekwang
    Yoon, Hyejin
    Basak, Jacob
    Kim, Jungsu
    [J]. MOLECULES AND CELLS, 2014, 37 (11) : 767 - 776
  • [15] A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's Disease
    Lambert, JC
    Pasquier, F
    Cottel, D
    Frigard, B
    Amouyel, P
    Chartier-Harlin, MC
    [J]. HUMAN MOLECULAR GENETICS, 1998, 7 (03) : 533 - 540
  • [16] Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease
    Lambert, JC
    Berr, C
    Pasquier, F
    Delacourte, A
    Frigard, B
    Cottel, D
    Pérez-Tur, J
    Mouroux, V
    Mohr, M
    Cécyre, D
    Galasko, D
    Lendon, C
    Poirier, J
    Hardy, J
    Mann, D
    Amouyel, P
    Chartier-Harlin, MC
    [J]. HUMAN MOLECULAR GENETICS, 1998, 7 (09) : 1511 - 1516
  • [17] Contribution of APOE promoter polymorphisms to Alzheimer's disease risk
    Lambert, JC
    Araria-Goumidi, L
    Myllykangas, L
    Ellis, C
    Wang, JC
    Bullido, MJ
    Harris, JM
    Artiga, MJ
    Hernandez, D
    Kwon, JM
    Frigard, B
    Petersen, RC
    Cumming, AM
    Pasquier, F
    Sastre, I
    Tienari, PJ
    Frank, A
    Sulkava, R
    Morris, JC
    St Clair, D
    Mann, DM
    Wavrant-DeVrièze, F
    Ezquerra-Trabalon, M
    Amouyel, P
    Hardy, J
    Haltia, M
    Valdivieso, F
    Goate, AM
    Pérez-Tur, J
    Lendon, CL
    Chartier-Harlin, MC
    [J]. NEUROLOGY, 2002, 59 (01) : 59 - 66
  • [18] Apolipoprotein E promoter polymorphisms (-491A/T and-427T/C) and Alzheimer's disease: no evidence of association in the Irish population
    Lynch, C. A.
    Brazil, J.
    Cullen, B.
    Coakley, D.
    Gill, M.
    Lawlor, B. A.
    Hawi, Z.
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2008, 177 (01) : 29 - 33
  • [19] Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease
    Nicodemus, KK
    Stenger, JE
    Schmechel, DE
    Welsh-Bohmer, KA
    Saunders, AM
    Roses, AD
    Gilbert, JR
    Vance, JM
    Haines, JL
    Pericak-Vance, MA
    Martin, ER
    [J]. NEUROGENETICS, 2004, 5 (04) : 201 - 208
  • [20] Lack of independent associations of apolipoprotein E promoter and intron 1 polymorphisms with Alzheimer's disease
    Rebeck, GW
    Cheung, BS
    Growdon, WB
    Deng, A
    Akuthota, P
    Locascio, J
    Greenberg, SM
    Hyman, BT
    [J]. NEUROSCIENCE LETTERS, 1999, 272 (03) : 155 - 158